Back to top
more

VERADIGM INC (MDRX)

(Delayed Data from OTC)

$4.80 USD

4.80
1,810

0.00 (0.00%)

Updated Jun 18, 2026 03:08 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (152 out of 247)

Industry: Medical Info Systems

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

What to Expect from Verisk Analytics' (VRSK) Q4 Earnings?

by Zacks Equity Research

Verisk Analytics' (VRSK) earnings and revenues are expected to have taken a hit by the disposition of parts of its energy and specialized market segments.

Shuvra Shankar Dey headshot

3 Service Stocks Poised to Beat Earnings Estimates in Q4

by Shuvra Shankar Dey

Here we pick three business service stocks, namely PagSeguro Digital (PAGS), Veradigm (MDRX) and TuSimple (TSP), which are likely to pull off earnings surprises this time around.

Zacks Equity Research

Green Dot (GDOT) to Report Q4 Earnings: What to Expect

by Zacks Equity Research

Green Dot's (GDOT) revenues and earnings seem to have suffered due to declining active accounts and increasing expenses.

Zacks Equity Research

Analysts Estimate TTEC Holdings (TTEC) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

TTEC (TTEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Will (MDRX) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

(MDRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

MDRX or VERI: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

MDRX vs. VERI: Which Stock Is the Better Value Option?

Zacks Equity Research

Syneos Health (SYNH) Signs New Partnership With Cryoport

by Zacks Equity Research

Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.

Zacks Equity Research

Masimo's (MASI) Patient Monitoring Devices Favored by New Study

by Zacks Equity Research

Masimo's (MASI) patient monitoring devices continue to aid researchers in their assessment of different ventilatory strategies for brain oxygenation during thoracoscopic surgery.

Zacks Equity Research

Strength Seen in Veradigm (MDRX): Can Its 5.0% Jump Turn into More Strength?

by Zacks Equity Research

Veradigm (MDRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Equity Research

Here's Why You Should Retain Veradigm (MDRX) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Veradigm (MDRX) owing to its strategic alliances.